Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Molecular Pharmaceutics
|
August 7, 2013
Enhanced cell death imaging using multivalent zinc(II)-bis(dipicolylamine) fluorescent probes
Bryan A Smith, Kara M Harmatys, Shuzhang Xiao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 12, 2022
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
Michel R Corboz, Adam J Plaunt, Vladimir S Malinin, et al.
ERJ Open Research
|
February 22, 2021
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
Richard W Chapman, Michel R Corboz, Carlos Fernandez, et al.
Pharmaceutics
|
September 28, 2023
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection
Donna M Konicek, Adam J Plaunt, Sachin Gharse, et al.
Drug Research
|
May 24, 2018
Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation
Franziska G Leifer, Donna M Konicek, Kuan-Ju Chen, et al.
Pulmonary Pharmacology & Therapeutics
|
February 9, 2018
Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil
Richard W Chapman, Zhili Li, Michel R Corboz, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
Adam J Plaunt, Sadikul Islam, Tony Macaluso, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 15, 2017
Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug
Michel R Corboz, Zhili Li, Vladimir Malinin, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2021
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Molecular Pharmaceutics
|
August 7, 2013
Enhanced cell death imaging using multivalent zinc(II)-bis(dipicolylamine) fluorescent probes
Bryan A Smith, Kara M Harmatys, Shuzhang Xiao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 12, 2022
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
Michel R Corboz, Adam J Plaunt, Vladimir S Malinin, et al.
ERJ Open Research
|
February 22, 2021
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
Richard W Chapman, Michel R Corboz, Carlos Fernandez, et al.
Pharmaceutics
|
September 28, 2023
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection
Donna M Konicek, Adam J Plaunt, Sachin Gharse, et al.
Drug Research
|
May 24, 2018
Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation
Franziska G Leifer, Donna M Konicek, Kuan-Ju Chen, et al.
Pulmonary Pharmacology & Therapeutics
|
February 9, 2018
Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil
Richard W Chapman, Zhili Li, Michel R Corboz, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
Adam J Plaunt, Sadikul Islam, Tony Macaluso, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 15, 2017
Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug
Michel R Corboz, Zhili Li, Vladimir Malinin, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2021
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Page
of 2